Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
2
×
national blog main
accelerated approval
acute hepatic porphyria
alnylam pharmaceuticals
aminolevulinic acid
biobucks
biotech
boston
calistoga pharmaceuticals
car-t immunotherapy
checkpoint inhibitors
clinical trials
drugs
gilead sciences
givosiran
idelalisib
immuno-oncology
kite pharma
kymriah
license
medicare
national top stories
rna interference
san francisco
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
tango therapeutics
yescarta
zydelig
What
drug
2
×
far
2
×
adding
alnylam
bets
boost
cancer
cleared
data
expensive
gilead
interference
market
medicine
million
nasdaq
new
ok
paying
pharmaceuticals
pipeline
program
rna
rnai
sciences
second
seek
speedy
startup
startup's
tango
tap
therapeutics
tiny
Language
Current search:
far
×
drug
×
" life sciences "
×
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
